Purchase Order 75F40126P00158
Award Date 8/5/26
Potential Completion Date 8/9/27
Potential Value $272K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, in the amount of $162,459.55. The contract is for the supply of bordetella-free baboons, with a period of performance ending on July 29, 2021. The contract was awarded on July 30, 2020 and was not set aside for any specific business category. MD Anderson Cancer...
- This is a firm fixed price purchase order issued by the Department of Health and Human Services Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center (MD Anderson), a component of the University of Texas System, to provide 24 age-matched, Bordetella-free weanling baboons for use in Pertussis infection and vaccination studies. The contract has a potential value of $187,360.62 and was awarded on April 19, 2019 under full and open competition, with no set-aside...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct a study on the duration of pertussis immunity in baboons. The contract has a ceiling value of $171,069.00 and a period of performance ending on February 28, 2025. The contract does not have a set-aside designation. MD Anderson Cancer Center is a comprehensive cancer treatment and...
- The Department of Health and Human Services Food and Drug Administration awarded a $143,340.00 firm fixed price purchase order to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct a one-year study on baboons that have recovered from Bordetella pertussis (whooping cough) infection. The study will assess the duration of immune responses to B. pertussis in the research animals. This award is not associated with any larger contract...
- This is a firm-fixed-price federal contract award valued at $425,645.08 from the Food and Drug Administration (FDA) to The University of Texas MD Anderson Cancer Center, a child entity of the University of Texas System. The contract is for an "IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES" and does not have a set-aside designation. MD Anderson, a leading academic cancer research and treatment institution, has extensive experience...
- This federal contract award, valued at $179,084.58, was issued by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research. The contract is for the supply of Bordetella-free weanling baboons, which will be used for research purposes. The Texas Biomedical Research Institute is a leading independent biomedical research organization that specializes in infectious disease research, particularly focusing on...
- The University of Texas MD Anderson Cancer Center, operating as the prime contractor, was awarded a $255,965 Delivery Order contract by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to provide Rhesus monkeys of Indian origin that are even gender and under two years of age in accordance with Request for Quote number NC42. The prime contractor will perform all work in Houston, Texas over an 11-month period ending July 8,...
- This is a federal contract award from the Office of Logistics and Acquisition Operations, a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson). The contract, with a ceiling value of $171,500.00, is for the acquisition, testing, transportation, and housing of non-human primate research colonies to support infectious disease and immunology studies at NIH facilities. The contract is a delivery order under a larger indefinite...
- This federal contract award was made by the Food and Drug Administration (FDA) to the Texas Biomedical Research Institute, doing business as the Southwest Foundation For Biomedical Research, for the provision of weanling baboons. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $90,000.00 and an ultimate completion date of March 23, 2016. The contract was awarded on August 28, 2015 without any set-aside designation. The Texas Biomedical Research Institute is a leading...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $32,070 firm fixed price delivery order to The University of Texas M.D. Anderson Cancer Center in response to Request for Quotation N60 for Bolivian squirrel monkeys greater than 750 grams in specific pathogen free conditions. Performance will occur in Houston, Texas by September 2022 with the University of Texas System serving as M.D. Anderson's parent organization....
Teaming
Find teaming partners for this award
The Food and Drug Administration awarded a purchase order to The University of Texas MD Anderson Cancer Center for a Bordetella-free baboon study with a ceiling value of $272,300.60, effective August 5, 2026. Work is performed in Houston, Texas, with an ultimate completion date of August 9, 2027. The contract uses firm fixed-price pricing with no set-aside category.
Generated 8/6/26, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $206.2k | 8/4/26 |